NewLimit
Extending human healthspan.
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- newlimit.com
- Total Funding
- $260.0M
- Last Round
- $45.0M Corporate RoundOct 2025
About
NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage technologies like single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions. Our first programs target the aging liver, immune, and vascular systems as stepping stones to significantly extending human healthspan.
Tech Stack
Machine Learning
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free Account